ZYXI
Zynex Inc
Price:  
1.15 
USD
Volume:  
162,575.00
United States | Health Care Equipment & Supplies
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Zynex WACC - Weighted Average Cost of Capital

The WACC of Zynex Inc (ZYXI) is 9.4%.

The Cost of Equity of Zynex Inc (ZYXI) is 14.95%.
The Cost of Debt of Zynex Inc (ZYXI) is 7.80%.

Range Selected
Cost of equity 12.90% - 17.00% 14.95%
Tax rate 20.60% - 22.90% 21.75%
Cost of debt 7.00% - 8.60% 7.80%
WACC 8.3% - 10.5% 9.4%
WACC

Zynex WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 1.97 2.17
Additional risk adjustments 0.0% 0.5%
Cost of equity 12.90% 17.00%
Tax rate 20.60% 22.90%
Debt/Equity ratio 1.71 1.71
Cost of debt 7.00% 8.60%
After-tax WACC 8.3% 10.5%
Selected WACC 9.4%

Zynex's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for Zynex:

cost_of_equity (14.95%) = risk_free_rate (4.15%) + equity_risk_premium (5.10%) * adjusted_beta (1.97) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.